PHC Holdings Corporation (PHCCF) fair value: what the stock is really worth
As of Sep 18, 2026: fair value of PHC Holdings Corporation $8.78, price $7.41, upside +18.5%, quality 56 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch PHC Holdings Corporation for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 23, 2026.
How to read this chart
40‑month range $5.52 – $10.00 · fair‑value band $5.57 – $13.55 · the $7.41 price screens below the $8.78 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 23, 2026.
Follow PHC Holdings in your weekly email
Every Wednesday you see whether PHC Holdings is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
PHC Holdings Corporation, together with its subsidiaries, provides healthcare digital and precision technology solutions in Japan, Europe, North America, and internationally. The company operates in three segments: Diabetes Management; Healthcare Solutions; and Diagnostic and Life Sciences.
Show more
PHC Holdings Corporation, together with its subsidiaries, provides healthcare digital and precision technology solutions in Japan, Europe, North America, and internationally. The company operates in three segments: Diabetes Management; Healthcare Solutions; and Diagnostic and Life Sciences. It offers precision anatomical pathology for cancer, including tissue processors, digital pathology, and histology consumables; cell growth and preservation, such as CFC-free ultra-low temperature freezers, CO2 incubators, and live cell metabolic analyzer and cell expansion bioreactor system; and diagnostic testing comprising clinical testing, diagnostic reagents, and digital diabetes management solutions. The company also provides patient record and billing solutions, which include electronic medical record systems and receipt systems, systems for pharmacies, and wellness and prevention; diabetes management technology, such as blood and continuous glucose monitoring systems; and medical device and drug delivery comprising contract development and manufacturing services, drug delivery systems, and digital health. It serves patients, healthcare professionals, and researchers. The company was formerly known as Panasonic Healthcare Holdings Co., Ltd. and changed its name to PHC Holdings Corporation in April 2018. PHC Holdings Corporation was founded in 1948 and is headquartered in Chiyoda, Japan.
Stock analysis
PHC Holdings Corporation (PHCCF) currently trades at $7.41, while our model-based Fair Value estimate is $8.78, implying the stock looks roughly 15.6% undervalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of $9.99 per share, and 15 of the 21 models we run sit above the $7.41 price.
Bear case: the Earnings-Based group reads lowest at $1.85, and 6 of the 21 models stay below the price. Evidence for this calculation is medium.
Scenario range: $5.57 (bear) to $13.55 (bull), the price of $7.41 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 56/100 (solid quality), in the Healthcare sector.
Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.
PHC Holdings Corporation reported revenue of ¥362B in FY2025 versus ¥306B in FY2021, a compound +4.3%/yr. Reported net income was ¥10.5B in FY2025, compounding −11.3%/yr from FY2021.
Key figures
Market cap $935M · P/E ratio 25.6 · P/S ratio 0.74 · EPS (TTM) $0.2900 · Dividend yield 3.6% · Net margin 2.9% · Return on equity 0.2% · Return on assets (EBIT) 2.6%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 50 out of 100 (low confidence).
What moves the price
The share trades about 21% below its 52-week high and 21% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at 5% fair-value upside, at 18%, PHCCF screens cheaper than that median.
Fair Value models
Bear $5.57Fair Value $8.78Bull $13.55
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.71/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Revenue growth 1 year
+2.2%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+2.0%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+5.8%
Start year 2020 (pandemic)
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years), in JPY ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in JPY: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+1.9%
Earnings growth per share plus dividend.
Earnings per share, growth per year−1.7%
Dividend (yield on the price)3.6%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.5% → 6%
Growth Forecast
Price in line with expectations
The price assumes less growth than the company has delivered so far and about what analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+1.4%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+1.3%
Yearly sales growth analysts expect, extended to five years.
After inflation (figures in JPY, Japan: IMF forecast 2.1% a year to 2030, 1.3% from 2016 to 2025) that is about −0.7% a year for the price and −0.7% for the forecasts.
Compare PHC Holdings Corporation with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Devices · 365 stocks
Beats the industry median on 6/11 measures
A mixed picture versus its industry peers.
Valuation
Quality Score56 · Above median
Fair Value upside+19% · Top 25%
Profitability
Return on equity (TTM)0% · Below median
Return on assets3% · Above median
Net margin (TTM)0% · Below median
Operating margin (TTM)6% · Below median
Growth and dividend
Revenue growth1% · Below median
Dividend yield (TTM)3.6% · Top 25%
Balance sheet
Debt / equity1.57× · Highest 25%
Valuation Multiplesvs Medical Devices median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is PHC Holdings Corporation (PHCCF) overvalued or undervalued?
As of Sep 23, 2026, our model estimates a fair value of $8.78 versus the last price from Sep 18, 2026 of $7.41, about +18% upside (undervalued).
What is the fair value of PHCCF?
Our model-based fair value for PHC Holdings Corporation is $8.78 (as of Sep 23, 2026), built from audited fundamentals. Last price (from Sep 18, 2026): $7.41.
What is the quality score of PHCCF?
PHC Holdings Corporation has a Quality Score of 56/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for PHC Holdings Corporation (PHCCF)?
Our model-based price target is the fair value of $8.78 (as of Sep 23, 2026) from 21 valuation models. Cautious scenario $5.57, optimistic scenario $13.55. It is a calculation from audited fundamentals, not an analyst target.
What is the PHC Holdings Corporation stock forecast for 2026?
Our models put fair value at $8.78, about +18% upside versus the last price from Sep 18, 2026 of $7.41 (undervalued). Cautious scenario $5.57, optimistic scenario $13.55. The calculation is refreshed regularly with new filings.
What is the revenue of PHC Holdings Corporation (PHCCF)?
PHC Holdings Corporation reported trailing-twelve-month revenue of about ¥364B (latest available figure, as of Sep 23, 2026).
Does PHC Holdings Corporation pay a dividend?
PHC Holdings Corporation currently shows a dividend yield of about 3.60% relative to its recent price (as of Sep 23, 2026).
What growth is priced into PHC Holdings Corporation (PHCCF)?
For today's price to be fair in a discounted-cash-flow model, PHC Holdings Corporation would have to grow free cash flow by +1.4 % per year for five years (discount rate 10.2 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +5.8 % per year. As of Sep 23, 2026.
What discount rate (WACC) does the fair value of PHCCF use?
Our models discount PHC Holdings Corporation at 10.2 %: a base by market capitalisation (small), damped by beta 0.64, country premium for USA. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For PHC Holdings Corporation that is +1.4 % per year a year over ten years, using the same discount rate (10.2 %) and the same formula as our fair value.
How much growth has PHC Holdings Corporation (PHCCF) delivered so far?
Over the past 5 years revenue at PHC Holdings Corporation grew +5.8 % a year. The price currently implies +1.4 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of PHC Holdings Corporation (PHCCF) growing?
The median revenue growth in the sector is +0.0 % a year. That is the yardstick for the growth priced into PHC Holdings Corporation (+1.4 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of PHC Holdings Corporation (PHCCF)?
The free-cash-flow yield on the price is 20.52 %: that much free cash flow PHC Holdings Corporation produces per unit of market value. When it exceeds the discount rate of our models (10.2 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of PHC Holdings Corporation (PHCCF)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For PHC Holdings Corporation it is $8.78 per share (as of Sep 23, 2026), against a price of $7.41. It is the blended result of 21 valuation models (cash flow, earnings, asset, dividend).
Is PHC Holdings Corporation stock overvalued or undervalued in 2026?
As of Sep 23, 2026, PHCCF trades below its calculated fair value: price $7.41, fair value $8.78, a gap of about +18% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of PHCCF?
No. The price is what the market pays today ($7.41); the fair value is what the company's own numbers justify ($8.78). For PHC Holdings Corporation the two are $1.37 per share apart. That gap is exactly why we show both numbers side by side.
How much is PHC Holdings Corporation worth?
The market values PHC Holdings Corporation at about $935M (market capitalisation, as of Sep 23, 2026). Per share that is $7.41; our models calculate a fair value of $8.78 per share.
What do the bullish and bearish scenarios say about PHCCF?
Our models span a range for PHC Holdings Corporation: cautious scenario $5.57, base $8.78, optimistic $13.55 per share (as of Sep 23, 2026, price $7.41). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of PHCCF?
PHC Holdings Corporation trades at a price-to-earnings ratio of 25.6 (as of Sep 23, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of $8.78 is built from several models across several years.
How solid is the balance sheet of PHC Holdings Corporation (PHCCF)?
Balance-sheet figures for PHC Holdings Corporation (as of Sep 23, 2026): return on equity 0.2%, debt of 1.57 per unit of equity. They feed the Quality Score of 56/100, which measures business quality independently of the share price.
How far is PHCCF from its 52-week high?
PHC Holdings Corporation trades at $7.41, about 21% below its 52-week high of $9.36 and 21% above the low of $6.12 (as of Sep 18, 2026). Distance from the high says nothing about value: that is what the fair value of $8.78 is for.
Which stocks are comparable to PHC Holdings Corporation?
From the same area (Healthcare) we also value Abbott Laboratories,, Medtronic plc, Stryker Corporation, Boston Scientific Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is PHC Holdings Corporation stock attractive at the current price?
The data as of Sep 23, 2026: price $7.41, calculated fair value $8.78 (+18%), Quality Score 56/100, from 21 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of PHCCF calculated?
We run PHC Holdings Corporation through 21 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $8.78, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.0 % above its aggregate fair value. PHC Holdings Corporation currently trades 18 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of PHC Holdings Corporation (PHCCF)?
The latest price we hold is from Sep 18, 2026 and stands at $7.41. Our model-based fair value is $8.78, about +18% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with PHC Holdings Corporation right now?
A fairly wide model range ($5.57 to $13.55) leaves room in how you read the outcome. The price sits in the lower half of our model range, the side with the larger margin of safety. Read the verdict with care: some models are missing inputs, so the estimate scatters more than usual.
Key figures of PHC Holdings Corporation
How large is the market capitalisation of PHC Holdings Corporation (PHCCF)?
The market capitalisation of PHC Holdings Corporation is $935M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of PHC Holdings Corporation (PHCCF)?
The price-to-sales ratio of PHC Holdings Corporation is 0.74 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of PHC Holdings Corporation (PHCCF)?
Earnings per share at PHC Holdings Corporation are $0.2900 (price ÷ EPS = P/E 25.6). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of PHC Holdings Corporation (PHCCF)?
The dividend yield of PHC Holdings Corporation is 3.6% (payout 92.0%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of PHC Holdings Corporation (PHCCF)?
The net margin of PHC Holdings Corporation is 2.9% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of PHC Holdings Corporation (PHCCF)?
The return on equity (ROE) of PHC Holdings Corporation is 0.2% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of PHC Holdings Corporation (PHCCF)?
On an EBIT basis the return on assets of PHC Holdings Corporation is 2.6% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of PHC Holdings Corporation (PHCCF)?
The operating margin of PHC Holdings Corporation is 5.9% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at PHC Holdings Corporation (PHCCF)?
Revenue at PHC Holdings Corporation is growing +0.5% versus a year earlier (3y avg +2.0%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at PHC Holdings Corporation (PHCCF)?
Earnings per share at PHC Holdings Corporation are growing −75.4% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does PHC Holdings Corporation (PHCCF) carry?
The net debt of PHC Holdings Corporation is ¥216B (fiscal year 2025, ≈ 7.1 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch PHC Holdings Corporation in the live analysis
One click puts PHC Holdings Corporation on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Some data
Sep 23, 2026